Newsroom
-
Mammoth Biosciences raises $195 million vaulting its CRISPR tech to unicorn status
ForbesLearn More -
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
TechCrunchLearn More -
Jennifer Doudna’s diagnostic spinout raises Mammoth round as it expands to therapies
Endpoints NewsLearn More -
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
Business WireLearn More -
Mammoth Biosciences Named to Fierce Medtech’s “Fierce 15” Companies of 2020 for Advancing Next Generation CRISPR Products in Diagnostics and Therapeutics
WebWireLearn More -